CCL2 and Bartsocas-Papas syndrome 1: Among the urinary biomarkers, which are higher in IC/BPS, eotaxin, MCP-1, TNF-α, 8-OHdG, and TAC were found to be significantly higher in IC/BPS patients than those in other LUTD subgroups.